Exhibit 10.44
CONSULTING AGREEMENT
THIS CONSULTING AGREEMENT (the “Agreement”) is entered into as of October 27, 2021 by and between Epizyme, Inc. (the “Company”), and Matthew Ros (“Mr. Ros” or “you”) (together, the “Parties”).
WHEREAS, Mr. Ros has served as the Executive Vice President, Chief Strategy and Business Officer of the Company;
WHEREAS the Executive Vice President, Chief Strategy and Business Officer position has been eliminated by the Company and consequently, Mr. Ros’ last date of employment with the Company will be October 31, 2021;
WHEREAS, the Company desires to engage Mr. Ros as a consultant to the Company effective immediately following his last date of employment with the Company; and
WHEREAS, Mr. Ros has agreed to provide such services pursuant to the terms and conditions set forth in this Agreement.
NOW, THEREFORE in consideration of the mutual covenants and promises contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Parties hereto, the Parties agree as follows:
1
2
6.1 Proprietary Information.
3
4
6.2 Inventions.
5
6
7
8
IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date and year first above written.
EPIZYME, INC.
By: /s/ Grant Bogle
Name: Grant Bogle
Title: Chief Executive Officer
/s/ Matthew Ros
Matthew Ros
9